強気
$9.12
シナリオ価格
$6.030
+0.186 (+3.08%)終値時点
AdaptHealth Corp. and subsidiaries are engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under three segments that align with its product categories: Sleep Health, Respiratory Health, and Wellness at Home. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. The Wellness at Home segment provides home medical equipment and services to patients in their homes, including those who have been discharged from acute care and other facilities.
Currently, AdaptHealth Corp (AHCO) is not a strong buy due to its recent financial struggles, including a significant Q2 loss of $1.07 per share compared to an expected profit of $0.15. The stock has also seen a year-to-date decline of 37.75%, indicating ongoing market challenges. However, insider buying has surged by 20850.77% over the last month, suggesting some confidence from company insiders. The current price of $6.02 is below the analyst price targets, which range from $9 to $10, indicating potential upside but also significant risks.
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

AdaptHealth to Release Q3 2026 Financial Results and Host Conference Call

AdaptHealth to Participate in Upcoming Investor Conferences

Launch of ReDream Brands Platform for Sleep Health

Analysis of Cash-Strong Stocks

AdaptHealth Reports Significant Q2 Revenue Miss and Loss
AdaptHealth Corp. and subsidiaries are engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under three segments that align with its product categories: Sleep Health, Respiratory Health, and Wellness at Home. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. The Wellness at Home segment provides home medical equipment and services to patients in their homes, including those who have been discharged from acute care and other facilities. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
Currently, AdaptHealth Corp (AHCO) is not a strong buy due to its recent financial struggles, including a significant Q2 loss of $1.07 per share compared to an expected profit of $0.15. The stock has also seen a year-to-date decline of 37.75%, indicating ongoing market challenges. However, insider buying has surged by 20850.77% over the last month, suggesting some confidence from company insiders. The current price of $6.02 is below the analyst price targets, which range from $9 to $10, indicating potential upside but also significant risks.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。